Judith C. W. Marsh

Judith C. W. Marsh publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Judith C. W. Marsh sits on this spectrum.

Judith C. W. Marsh D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Judith C. W. Marsh sits on this spectrum.

Overview

Best Publications

• Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria.

  Peter Hillmen;Claire Hall;Judith C W Marsh;Modupe Elebute

  872
  Citations

• Guidelines for the diagnosis and management of adult aplastic anaemia.

  Sally B Killick;Nick Bown;Jamie Cavenagh;Inderjeet Dokal

  738
  Citations

• Guidelines for the diagnosis and management of aplastic anaemia

  Judith C. W. Marsh;Sarah E. Ball;Jamie Cavenagh;Phil Darbyshire

  702
  Citations

• In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation.

  Panagiotis D Kottaridis;Donald W Milligan;Rajesh Chopra;Ronjon Chakraverty

  611
  Citations

• A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction.

  Howard A. Pearson;Jeffrey S. Lobel;Samuel A. Kocoshis;J. Lawrence Naiman

  530
  Citations

• The use of 7-amino actinomycin D in identifying apoptosis : Simplicity of use and broad spectrum of application compared with other techniques

  N. J. Philpott;A. J. C. Turner;J. Scopes;M. Westby

  476
  Citations

• Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT* SAA Working Party

  A. Bacigalupo;J. Hows;E. Gluckman;C. Nissen

  475
  Citations

• Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015

  A. Sureda;P. Bader;S. Cesaro;P. Dreger

  435
  Citations

• Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--The European Group for Blood and Marrow Transplantation experience.

  Andrea Bacigalupo;Ronald Brand;Rosi Oneto;Barbara Bruno

  389
  Citations

• Progressive Telomere Shortening in Aplastic Anemia

  Sarah E. Ball;Frances M. Gibson;Siân Rizzo;Jennifer A. Tooze

  364
  Citations

• Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia.

  Hubert Schrezenmeier;Jakob R. Passweg;Judith C. W. Marsh;Andrea Bacigalupo

  358
  Citations

• Allogeneic stem-cell transplantation using a reduced- intensity conditioning regimen has the capacity to produce durable remissions and long-term disease- free survival in patients with high-risk acute myeloid leukemia and myelodysplasia

  Sudhir Tauro;Charles Craddock;Karl Peggs;Gulnaz Begum

  317
  Citations

• TP53 mutations in myelodysplastic syndrome are strongly correlated with aberrations of chromosome 5, and correlate with adverse prognosis.

  Austin Gladston Kulasekararaj;Alexander E. Smith;Syed Mian;Azim M. Mohamedali

  302
  Citations

• Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party.

  J. Marsh;H. Schrezenmeier;P. Marin;O. Ilhan

  279
  Citations

• Growth of human umbilical-cord blood in longterm haemopoietic cultures

  J.M. Hows;J.C.W. Marsh;T. Luft;L. Coutinho

  277
  Citations

• The EBMT activity survey: 1990-2010.

  J R Passweg;H Baldomero;A Gratwohl;M Bregni

  271
  Citations

• The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation.

  David I Marks;Richard Lush;Jamie Cavenagh;Donald W Milligan

  269
  Citations

• Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA working party

  Andrea Bacigalupo;Gerard Socie;Edoardo Lanino;Arcangelo Prete

  268
  Citations

• A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation.

  André Tichelli;Hubert Schrezenmeier;Gérard Socié;Judith Marsh

  261
  Citations

• Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome

  Austin G. Kulasekararaj;Austin G. Kulasekararaj;Jie Jiang;Jie Jiang;Alexander E. Smith;Alexander E. Smith;Azim M. Mohamedali;Azim M. Mohamedali

  259
  Citations